EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury

Quanxian Liu, Lu Huang, Hong Yan, Zhaojing Zong, Zhenyong Chen, Xiaoyan Wu, Ling Chen, Yuanbo Lan

Frontiers in Pharmacology · 23.07.2024 · 15

DOI: 10.3389/fphar.2024.1406454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.07.2024. Verfasst von Quanxian Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the clinical and laboratory characteristics and to identify predictors of moderate to severe anti-tuberculosis drug-induced liver injury (ATB-DILI) in patients with tuberculosis.

Methods

This prospective study enrolled Tuberculosis (TB) patients treated with first-line anti-tuberculosis drugs at the Affiliated Hospital of Zunyi Medical University between May 2022 and June 2023. The occurrence of ATB-DILI was monitored, and demographic and clinical data were gathered. We analyzed risk factors for the development of moderate to severe ATB-DILI.

Results

ATB-DILI was detected in 120 (10.7%) of the patients, with moderate to severe ATB-DILI occurring in 23 (2.0%) of the 1,124 patients treated with anti-tuberculosis treatment. Multivariate cox regression analysis identified malnutrition (HR = 4.564, 95% CI: 1.029–20.251, p = 0.046) and hemoglobin levels <120 g/L (HR = 2.825, 95% CI: 1.268–11.540, p = 0.017) as independent risk factors for moderate to severe ATB-DILI.

Conclusion

The incidence of moderate to severe ATB-DILI was found to be 2.0%. Malnutrition and hemoglobin levels below 120 g/L emerged as significant independent risk factors for the occurrence of moderate to severe ATB-DILI in this patient population.

Schlagwörter

Stichwörter der Autor:innen

drug-induced liver injuryhaemoglobinmalnutritionmoderate and severe ATB-DlLlrisk factor

Autor:innen und Institutionen

  • Department of Tuberculosis, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Zitieren

APA

Liu, Q., Huang, L., Yan, H., Zong, Z., Chen, Z., Wu, X., Chen, L., & Lan, Y. (2024). Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1406454

Vancouver

Liu Q, Huang L, Yan H, Zong Z, Chen Z, Wu X, et al. Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1406454

BibTeX
@article{Liu2024,
  author = {Liu, Quanxian and Huang, Lu and Yan, Hong and Zong, Zhaojing and Chen, Zhenyong and Wu, Xiaoyan and Chen, Ling and Lan, Yuanbo},
  title = {Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1406454}
}
Kostenlos starten →